Yan Bi Selected Research

Yan Bi Research Topics

Disease

36	Type 2 Diabetes Mellitus (MODY) 04/2022 - 04/2008
28	Insulin Resistance 06/2022 - 12/2008
12	Inflammation (Inflammations) 04/2022 - 01/2010
12	Non-alcoholic Fatty Liver Disease 01/2022 - 02/2016
10	Pancreatitis 01/2022 - 08/2015
9	Weight Loss (Weight Reduction) 06/2022 - 09/2015
9	Body Weight (Weight, Body) 06/2022 - 01/2013
9	Obesity 06/2022 - 09/2009
6	Glucose Intolerance 01/2018 - 08/2011
5	Chronic Pancreatitis 10/2021 - 01/2019
5	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 06/2021 - 07/2012
4	Overweight 06/2022 - 01/2018
4	Neoplasms (Cancer) 06/2022 - 10/2014
4	Schizophrenia (Dementia Praecox) 01/2022 - 09/2015
4	Hypoglycemia (Reactive Hypoglycemia) 06/2021 - 06/2012
4	Fibrosis (Cirrhosis) 01/2021 - 05/2014
4	Hyperglycemia 01/2021 - 01/2011
4	Major Depressive Disorder (Major Depressive Disorders) 01/2020 - 12/2018
3	Pancreatic Neoplasms (Pancreatic Cancer) 06/2022 - 10/2014
3	Cognitive Dysfunction 01/2022 - 01/2021
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2021 - 01/2018
3	Weight Gain 01/2020 - 06/2012
3	Diabetes Mellitus 03/2015 - 08/2012
2	Hypertension (High Blood Pressure) 06/2021 - 01/2018
2	Metabolic Diseases (Metabolic Disease) 01/2021 - 01/2019
2	Hypoxia (Hypoxemia) 12/2020 - 01/2020
2	Heart Failure 01/2020 - 09/2018
2	Endotoxemia 01/2020 - 07/2017
2	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2020 - 11/2019
2	Liver Diseases (Liver Disease) 03/2019 - 01/2016
2	Hyperandrogenism 01/2019 - 01/2018
2	Mental Disorders (Mental Disorder) 01/2019 - 12/2016
2	Dyslipidemias (Dyslipidemia) 07/2018 - 01/2011
2	Liver Cirrhosis (Hepatic Cirrhosis) 05/2014 - 07/2013
2	Malaria 04/2012 - 06/2008
1	Adenocarcinoma 06/2022
1	Celiac Disease (Celiac Sprue) 06/2022
1	Bacterial Infections (Bacterial Infection) 01/2022

Drug/Important Bio-Agent (IBA)

24	Insulin (Novolin)FDA Link 06/2022 - 12/2008
19	Glucose (Dextrose)FDA LinkGeneric 03/2021 - 01/2010
10	Metformin (Glucophage)FDA LinkGeneric 06/2022 - 06/2015
9	Hypoglycemic Agents (Hypoglycemics)IBA 12/2021 - 04/2008
9	Blood Glucose (Blood Sugar)IBA 06/2021 - 01/2013
7	Triglycerides (Triacylglycerol)IBA 01/2022 - 06/2009
7	LipidsIBA 01/2021 - 08/2012
5	Insulin Glargine (Lantus)FDA Link 06/2021 - 01/2018
5	Hemoglobins (Hemoglobin)IBA 05/2021 - 06/2018
5	Erythropoietin FDA Link 08/2019 - 01/2013
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2013
4	Liraglutide FDA Link 01/2022 - 08/2017
4	Glucagon-Like Peptide-1 Receptor AgonistsIBA 09/2018 - 06/2012
4	Exenatide (Byetta)FDA Link 06/2018 - 10/2014
4	Sterol Regulatory Element Binding Protein 1IBA 07/2017 - 03/2014
3	Pharmaceutical PreparationsIBA 01/2022 - 10/2014
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2010
3	AndrogensIBA 03/2021 - 01/2018
3	Indicators and Reagents (Reagents)IBA 03/2021 - 04/2012
3	CeruletideIBA 01/2021 - 01/2019
3	ProlactinIBA 01/2020 - 01/2018
3	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 01/2020 - 12/2018
3	Gliclazide (Diamicron)IBA 03/2019 - 08/2012
3	ElementsIBA 06/2015 - 03/2014
3	SterolsIBA 06/2015 - 03/2014
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 03/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2021
2	NAD (NADH)IBA 09/2021 - 01/2021
2	LDL CholesterolIBA 05/2021 - 07/2018
2	CollagenIBA 12/2020 - 01/2019
2	Antidepressive Agents (Antidepressants)IBA 01/2020 - 05/2019
2	TrypsinIBA 01/2020 - 01/2019
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2020 - 01/2018
2	TrypsinogenIBA 01/2020 - 01/2019
2	nasIBA 01/2020 - 10/2018
2	Biphasic InsulinsIBA 06/2019 - 06/2012
2	Neutralizing AntibodiesIBA 01/2019 - 05/2014
2	Testosterone (Sustanon)FDA Link 01/2018 - 01/2016
2	Phosphotransferases (Kinase)IBA 08/2017 - 10/2014
2	AMP-Activated Protein KinasesIBA 07/2017 - 06/2015
2	SilymarinIBA 01/2017 - 01/2016
2	pigment epithelium-derived factorIBA 09/2015 - 01/2013
2	acetovanillone (apocynin)IBA 01/2011 - 01/2010
2	CytokinesIBA 01/2009 - 12/2008
2	NF-kappa B (NF-kB)IBA 01/2009 - 12/2008
1	Glutens (Glutelin)IBA 06/2022
1	MLN 8237IBA 06/2022
1	Aurora Kinase AIBA 06/2022
1	glucagon-like peptide 1 (7-36)IBA 06/2022
1	Glucagon-Like Peptide 1 (GLP 1)IBA 06/2022
1	erucylphosphocholineIBA 04/2022
1	Apolipoproteins E (ApoE)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	dapagliflozinIBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	LuciferasesIBA 01/2022

Therapy/Procedure

23	Therapeutics 04/2022 - 04/2008
8	Glycemic Control 06/2021 - 05/2010
4	Bariatric Surgery 05/2021 - 01/2018
2	Drug Therapy (Chemotherapy) 06/2022 - 09/2015
2	Transplantation 01/2022 - 10/2021
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2021 - 01/2019